The Human Apolipoprotein 5-plex ProcartaPlex Panel is a preconfigured multiplex immunoassay kit that measures 5 protein targets using Luminex xMAP technology
The Human MER Simplex ProcartaPlex kit measures MER protein and is designed to be combinable with other Simplex kits so that you can create your own multiplex panel that utilizes Luminex xMAP technology for protein detection/quantitation.
The Maxpar Direct Immune Profiling Assay™ sets a new standard for comprehensive immunophenotyping of human PBMC and whole blood by enabling simultaneous identification and enumeration of 37 immune cell subsets. 30 markers. 1 tube. 5-minute data analysis.
Current metal conjugation protocols can be complex and time consuming procedures, and may result in low antibody recovery. Lightning-Link Metal Labeling Kits allow metal / antibody labeling to be set up in less than 30 seconds – simply add the antibody solution to the activated metal ligand!
The Ceres Nanosciences Nanotrap® Virus Capture Kit provide a way to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods
The Ceres Nanosciences Nanotrap® Virus Capture Kit provide a way to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods
2mL of Nanotrap ® Non-Magnetic Virus Particles (10 x 0.2 mL)
Gyrolab xPand is a high-throughput, compact disk (CD) based microfluidic immunoassay platform for unattended parallel processing of up to 5 CDs, generating 560 data points in 5 hours.
Gyrolab xPlore is a single-CD, cost-effective microfluidic immunoassay platform for unattended parallel processing of 96 or 112 data points in one hour.
The Quantikine Human BLC/BCA-1 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human BLC/BCA-1 in cell culture supernates, serum, plasma, and saliva.
Platelia SARS-CoV-2 Total Ab Assay. Detection of IgM, IgA and IgG in One Test.
CE-marked Enzyme Immunoassay (ELISA) kits for the detection of IgG and IgM antibodies to SARS-CoV-2 in human serum
The COVID-19 ImmunoRank™ Neutralization MICRO-ELISA test for detection of circulating SARS-CoV-2 neutralizing antibodies. The assay is designed to detect antibodies of all Ig classes in human plasma or serum that bind to the SARS-CoV-2 receptor binding domain (RBD) and are capable of blocking the binding of the RBD to angiotensin-converting enzyme 2 (ACE2), the viral entry receptor on the surface of target cells.
Nanotrap ® Magnetic Virus Particles
The Quick SARS-CoV-2 rRT-PCR Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).
C083 Cellulose Fiber Sample Pad Sheets for use in lateral flow, assay development, lateral flow immunoassays, lateral flow assay devices & immunoassay IVDs
Immunoassay for the qualitative detection of antibodies (incl. IgG) against SARS-CoV-2
The AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
Rapid nucleic acid detection post isothermal amplification for decentralised, point of care molecular testing
Provides sensitive and specific measurements of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.
Provides sensitive and specific quantitation of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.
Humasis COVID-19 Ag Test uses monoclonal antibodies specific to COVID-19 specific antigens in human nasopharyngeal swab specimens. The kit contains test devices, disposable test tubes, filter caps, and sterilized swabs for specimen collection for 25 tests.
Euroimmun offers ChLIA and ELISA tests for fast and efficient measurement of faecal calprotectin in stool samples. The analysis supports the diagnostic differentiation between chronic inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS) in line with current international guidelines. The assays are fully automatable, with random-access processing available for the ChLIA.
